HIGH
Ketamine Hydrochloride, 50mg/5 mL (10mg/mL), Injection for IV use, 50 mL syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0156-02.
Labeling: Incorrect or Missing Lot and/or Exp Date
STAQ Pharma
Labeling: Incorrect
HIGH
Applied Medical Technology Recalls Nasal Feeding Tubes Due to Detachment Hazard
Applied Medical Technology recalled 1,780 NutraGlide Nasal Feeding Tubes on August 12, 2025, after reports of distal tips detaching. This recall affects tubes distributed in Massachusetts and Rhode Island. The detachment poses a high risk for patients requiring enteral nutrition.
Quick Facts at a Glance
- Recall Date
- August 12, 2025
- Hazard Level
- HIGH
- Brand
- Applied Medical Technology
- Category
- Health & Personal Care
- Sold At
- Multiple Retailers
- Geographic Scope
- 2 states
- At-Risk Groups
- GENERAL
Hazard Information
The nasal feeding tubes, NutraGlide, subject to this recall have distal tips that may detach at lower than expected forces.
What You Should Do
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Applied Medical Technology Inc or your healthcare provider for instructions. Notification method: Letter
Product Details
The recall includes NutraGlide Nasal Feeding Tubes with Stylet and ENFit, sizes 5 F - 6 F x 55, REF E NRT-05055-I. These tubes were distributed in the US, specifically in Massachusetts and Rhode Island.
The Hazard
The distal tips of the NutraGlide Nasal Feeding Tubes may detach at lower than expected forces. This defect poses a significant risk to patients who depend on these feeding tubes for nutrition, fluids, and medications.
Reported Incidents
There have been no reported injuries or incidents associated with this recall. The potential for detachment remains a serious concern for patient safety.
What to Do
Patients and healthcare providers should stop using the NutraGlide Nasal Feeding Tubes immediately. Follow the recall instructions provided by Applied Medical Technology Inc. Contact the manufacturer or your healthcare provider for further instructions.
Contact Information
For more information, contact Applied Medical Technology Inc. at [insert phone number]. Additional details can be found on their website or through the FDA recall notice.
Key Facts
- Recall date: August 12, 2025
- Quantity recalled: 1,780 units
- Distribution limited to MA and RI
- High hazard level due to potential detachment
Get Alerts for Health & Personal Care Recalls
Get notified about recalls in categories you care about.
Safety Assessment
Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER
Product Classification
Product TypeNasal Feeding Tube
Sold At
Multiple Retailers
Product Details
Categories
Model Numbers
REF E NRT-05055-I
Affected States
MA, RI
Report Date
October 15, 2025
Source Agency
FDA - Medical Devices
Recall Status
ACTIVE
Related Recalls
HIGH
Sucralfate Tablets, USP 1 gram, 100 Tablets, (10x10), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC 60687-695-01 - Carton NDC [60687-695-11- Unit Dose]
CGMP Deviations: The recalling firm filed for Chapter 11 on September 30, 2024. As a result, it cannot monitor the quality program and hence cannot assure that products meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess, rendering the products adulterated.
SUCRALFATE
CGMP Deviations:
HIGH
Hydromorphone HCL PF, 10mg/50 mL (0.2mg/mL) in NACL, Injection for IV use, 50 mL Syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0104-05.
Labeling: Incorrect or Missing Lot and/or Exp Date
STAQ Pharma
Labeling: Incorrect